Format

Send to

Choose Destination
See comment in PubMed Commons below
Psychiatry (Edgmont). 2009 Aug;6(8):27-8.

The use of duloxetine in chronic bulimia nervosa: a case report.

Author information

1
Dr. Christensen is Professor and Chief of the Division of Public Psychiatry at the University of Florida College of Medicine.

Abstract

Selective serotonin reuptake inhibitors are routinely prescribed as off-label treatments for bulimia nervosa. There is, however, a paucity of literature addressing the efficacy of the serotonin norepinephrine reuptake inhibitors in the pharmacologic management of this disorder. This article describes a clinical situation in which duloxetine, a serotonin norepinephrine reuptake inhibitor, effectively treated a patient with long-standing bulimia nervosa, purging type, and comorbid generalized anxiety disorder.

KEYWORDS:

Bulimia nervosa; duloxetine; pharmacological management; serotonin norepinephrine reuptake inhibitors; serotonin reuptake inhibitors

PMID:
19763204
PMCID:
PMC2743210
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center